SOBRsafe Strengthens Leadership with Board and Scientific Advisory Appointments
SOBRsafe Inc. enhances its strategic capabilities by appointing Kris Pederson to its Board of Directors and Dr. Benjamin Sanchez as a Scientific Advisor, signaling a commitment to advancing its alcohol detection technology platform.
SOBRsafe Inc. has appointed two key leadership figures to strengthen its technological and governance capabilities. Kris Pederson, a veteran corporate director with extensive experience at prominent firms like EY, IBM, and PwC, will join the Board of Directors effective May 1, 2025, and will chair the Nominating and Corporate Governance Committee.
Simultaneously, the company named Dr. Benjamin Sanchez as a Scientific Advisor in February, bringing specialized expertise in biomedical engineering to support the company's federal funding and clinical research partnerships. These strategic appointments underscore SOBRsafe's commitment to innovation in alcohol detection technology.
SOBRsafe addresses a critical public health challenge, as alcohol misuse remains the fourth leading cause of preventable death in the United States and seventh globally. The company's unique transdermal technology offers a non-invasive, instantaneous method of alcohol detection through skin-based sensors, providing solutions for behavioral health, judicial, and consumer markets.
The addition of Pederson and Sanchez brings deep expertise in digital innovation and scientific research, positioning SOBRsafe to expand its technological capabilities and governance framework. Their appointments suggest the company is focused on scaling its alcohol detection platform and enhancing its strategic approach to addressing substance misuse prevention.